LoHud | Ad Sales | Company

Morningstar® Investment Profileâ„¢

Â Â Â View: Â Â

Progenics Pharmaceuticals, Inc.Â Â PGNX

Data as of 11-23-2009 10:53 AM CT


Last Price	Day Change	Volume
$4.08	0.01 (0.25%)	186,429



Open Price	Day Range	52-Wk Range
$4.15	4.20 - 4.04	10.81 - 3.53



Mkt Cap($mil)	Yield	Avg Volume
129	0.00 %	195,337



P/E	P/S	P/CF
	3.22

Â Stock Chart

Â Key Stats


Morningstar Style Box	Small Core	Stock Type	Speculative Growth
Industry	Biotechnology	Sector	Health Care
Market CapÂ $Mil	129	SalesÂ $Mil	39

Â Company Profile

What Does This Company Do?

Progenics develops biopharmaceutical drugs in supportive care, virology, and oncology. The firm previously partnered with Wyeth on its first marketed product, Relistor, which treats opioid-induced constipation. Progenic's other pipeline candidates include an oral form of Relistor and multiple drugs and vaccines for prostate cancer and HIV.

Address	777 Old Saw Mill River Road
Â	Tarrytown,Â NY,Â 10591
Phone	1 914 789-2800
Website	http://www.progenics.com
Employees	244
Direct Investment		No
Dividend Reinvestment		No

Quotes for Nasdaq securities are delayed 15 minutes. Quotes for NYSE and Amex securities are delayed 20 minutes, and are supplied by www.sdsmarketwatch.com. Graph Times are Eastern Standard. Copyright© 2008.

Show Data Definitions